genOway SA

As of December 31, 2025, genOway SA carries a market capitalization of 33.88M, placing it among publicly traded companies globally. Its enterprise value stands at 40.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, genOway SA has 12.10M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, genOway SA maintains a current ratio of 3.14, meaning it holds 3.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, genOway SA's stock has declined approximately 14.66% over the past 52 weeks. The 50-day moving average sits at 2.42, while the 200-day moving average is 2.37.

As of December 31, 2025, genOway SA holds 7.05M in cash and equivalents against 13.77M in total debt, resulting in a net debt position of 13.22M. Total book value stands at 24.97M, with working capital of 15.61M providing operational flexibility.